VESICARE - Medsafe
8. Patients with severe renal impairment or moderate hepatic impairment and on treatment with a strong CYP3A4 inhibitor, e.g. ketoconazole. (See also
Download VESICARE - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
What You Should Know About Your Diet and Warfarin
www.impactteam.infoWhat You Should Know About Your Diet and Warfarin What is warfarin? Warfarin is a medication that helps “thin” your blood to decrease your body’s chance of forming harmful
Patient Information (Please Print)
www.mdlab.com*Reflex to antibiotic resistance by Molecular Analysis. ♦Reflex to metronidazole resistance by Real-Time PCR.** Reflex to azithromycin resistance by Pyrosequencing. Ψ Reflex to …
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.euSubstances that inhibit CYP3A4 may decrease the clearance of gefitinib. Concomitant administration with potent inhibitors of CYP3A4 activity (e.g. ketoconazole, posaconazole, voriconazole, protease
HIGHLIGHTS OF PRESCRIBING INFORMATION Infusion …
www.astellas.us2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE 1.1 Invasive Aspergillosis CRESEMBA® is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [see Clinical Studies (14.1) and Clinical Pharmacology (12.4)]. 1.2 Invasive Mucormycosis CRESEMBA is an azole antifungal indicated for patients 18 years of age and older for …
ZĀĻU APRAKSTS 15 mg 20 mg - lfb.lv
www.lfb.lv3 Ja devas lietošana tiek aizmirsta, pacientam Xarelto jālieto nekavējoties un nākamajā dienā jāturpina zāļu lietošana vienu reizi dienā atbilstoši ieteikumiem.
Cariprazine for the Treatment of Schizophrenia: A Review ...
www.clinicalschizophrenia.netCariprazine is an antipsychotic medication and received approval by the U.S. Food and Drug Administration for the treatment of schizophrenia in September 2015.
Carbamazepine: Watch for Many Potential Drug Interactions
www.hanstenandhorn.comTable 1 Selected Drugs Whose Elimination May Be Increased by Carbamazepine Amitriptyline Aripiprazole (Abilify) Atorvastatin (Lipitor) Citalopram (Celexa)
Get to Know an Enzyme: CYP3A4 - Hansten and Horn
www.hanstenandhorn.comDrs. Horn and Hansten are both profes-sors of pharmacy at the University of Washington School of Pharmacy. For an electronic version of this article, includ-
Cordarone Ant Intravenous - Amiodarone-IV
amiodaroneiv.comCordarone I.V. also can be used to treat patients with VT/VF for whom oral Cordarone is indicated, but who are unable to take oral medication. During or after treatment with Cordarone I.V., patients may be